Stage 4 (TXN2cM1b)-- 2008 WLE, SNB, LND, HD-INF, GM-CSF, (intransits) 2013 IPI, (intransits) 2014 PEMBRO, (intransits and lung met) 2016 VATs
See more on www.melanomaforum.org
Anybody know why that NCT02083484 does not come up in clinicaltrials.gov ? Am I doing something silly?
This is certainly great news they are finally expanding this med.
Oh I see on MIF. Catherine Poole said it hasn't been added yet.
Should be there anytime, certainly by tomorrow.
This is such great news and I am excited for all of you who may go this route. I spoke with someone at Merck this week and they said to have your oncologist call. The woman led me to believe it is available now. That being said I am not sure she knew for sure. There were a few things I asked and she had absolutely no knowledge of. Good luck to all of you who may have been waiting for this news. Hang in there.
Love and Light
If this online community is valuable to you, please consider making a tax-deductible gift to support the MRF.
Meet and talk to others about melanoma in our forums:
See also: History of the MPIP Forum
–CURE OM Forum
Questions to Ask Your Doctor
Email the MRF Nurse
Get matched with a Phone Buddy
View the Melanoma Glossary
Raise awareness and funds to fight melanoma by participating in a Miles for Melanoma 5k walk/run this year!
Find a Miles for Melanoma event near you.
Patient Helpline: (877) 673-6460
1411 K Street, NW Suite 800
Washington, DC 20005
(800) 673-1290 Office
(202) 347-9678 Fax
The Melanoma Research Foundation (MRF) is leading the melanoma community to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy.
The Melanoma Research Foundation is a 501(c)(3) non-profit organization.